Tevogen Bio CEO Dr. Ryan Saadi Expresses Gratitude for Prestigious ROI-NJ Recognition, Highlighting Company's Novel Business Model as Key to Sustainable Success Through Patient Affordability

GlobeNewswire11/06 05:43

Tevogen Investors Congratulate on Prestigious Recognition of Pioneering Biopharma Business Model, Breakthrough Innovations, Building Assets Estimated to Exceed $10 Billion

GlobeNewswire10/17 19:54

10-Q：Q2 2024 四半期報告書

SEC08/15 04:44

Ryan Saadi Congratulates Marc Benioff on Receiving the Yale Legend in Leadership Award and Commends Yale School of Management for Recognizing the Importance of Integrating Corporate Success With Social Responsibility

GlobeNewswire07/09 04:07

Tevogen Bio Files Registration Statement for Previously Disclosed Securities; Does Not Relate to Any Previously Undisclosed New Issuances of Dilutive Securities

GlobeNewswire06/27 00:46

Tevogen Bio Set to Join Russell 3000 Index

Globe Newswire06/13 03:45